Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification.
Publication
, Preprint
Blackmer, JE; Jezuit, EA; Chakraborty, A; Montague, RA; Peterson, NG; Outlaw, W; Fox, DT
February 20, 2025
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Blackmer, J. E., Jezuit, E. A., Chakraborty, A., Montague, R. A., Peterson, N. G., Outlaw, W., & Fox, D. T. (2025). Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification. https://doi.org/10.1101/2025.02.19.639165
Blackmer, Jane E., Erin A. Jezuit, Archan Chakraborty, Ruth A. Montague, Nora G. Peterson, William Outlaw, and Donald T. Fox. “Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification.,” February 20, 2025. https://doi.org/10.1101/2025.02.19.639165.
Blackmer JE, Jezuit EA, Chakraborty A, Montague RA, Peterson NG, Outlaw W, et al. Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification. 2025.
Blackmer, Jane E., et al. Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification. 20 Feb. 2025. Pubmed, doi:10.1101/2025.02.19.639165.
Blackmer JE, Jezuit EA, Chakraborty A, Montague RA, Peterson NG, Outlaw W, Fox DT. Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification. 2025.